Evaluating the cost-benefit profile of CPI stem cell therapy necessitates a comprehensive approach. Supporters often emphasize the possibility for meaningful therapeutic outcomes, principally in conditions where conventional medications have proven inadequate. However, this is to consider the substantial financial expenditure associated with CPI st